Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research and development, commercialization, and sale of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. Its portfolio of products includes treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia (CAH), and endometriosis and uterine fibroids. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
1,800
Frequently Asked Questions
What is Market Cap of Neurocrine Biosciences, Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Neurocrine Biosciences, Inc. market cap is $14.3B.
What is the 52-week high for Neurocrine Biosciences, Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Neurocrine Biosciences, Inc. 52 week high is $154.61 as of September 10, 2025.
What is the 52-week low for Neurocrine Biosciences, Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Neurocrine Biosciences, Inc. 52 week low is $84.23 as of September 10, 2025.
What is Neurocrine Biosciences, Inc. stock price today?
Neurocrine Biosciences, Inc. stock price today is $140.61.
What was Neurocrine Biosciences, Inc. stock price yesterday?
Neurocrine Biosciences, Inc. stock price yesterday was $144.17.
What is the PE ratio of Neurocrine Biosciences, Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Neurocrine Biosciences, Inc.’s P/E ratio is 42.55.
What is the Price-to-Book ratio of Neurocrine Biosciences, Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Neurocrine Biosciences, Inc. P/B ratio is 5.2974.
What is the 50-day moving average of Neurocrine Biosciences, Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Neurocrine Biosciences, Inc. 50-day moving average is $133.05.
How many employess does Neurocrine Biosciences, Inc. has?
